会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL PIPRAZINE CARBOXAMIDES
    • 新型哌嗪羧酰胺
    • WO1994003436A1
    • 1994-02-17
    • PCT/SE1993000639
    • 1993-07-22
    • KABI PHARMACIA ABABRAMO, LisbethNORDVI, CurtLUNDSTEDT, TorbjörnOLSSON, Knut, GunnarBRODSZKI, Martin
    • KABI PHARMACIA AB
    • C07D241/04
    • C07D295/215C07D213/74
    • The present invention concerns novel compounds of general formula (I) wherein R1 and R2 are the same or different and selected from hydrogen or lower alkyl; wherein Ar are the same or different and selected from (II) and (III) wherein R3 is halogen or hydrogen. n is 2 or 3, X is nitrogen or methine. When X is nitrogen Y is methylene. When X is methine Y is selected from nitrogen or oxygen. A is selected from the carboxylic derivatives (IV) and (V) wherein R4 and R5 are the same or different and selected from hydrogen, alkyl, cycloalkyl or aryl. Z is selected from sulfur or oxygen. R6 is selected from (VI) and (VII) wherein m is 1, 2, 3 or 4. R7 is selected from hydrogen or lower alkyl, and the pharmacologically active salts thereof. The new compounds are useful for treating mental disorders.
    • 本发明涉及通式(I)的新化合物,其中R 1和R 2相同或不同并选自氢或低级烷基; 其中Ar相同或不同,并且选自(II)和(III),其中R 3是卤素或氢。 n为2或3,X为氮或次甲基。 当X是氮时,Y是亚甲基。 当X为次甲基时,Y选自氮或氧。 A选自羧酸衍生物(IV)和(V),其中R 4和R 5相同或不同,并且选自氢,烷基,环烷基或芳基。 Z选自硫或氧。 R6选自(VI)和(VII)其中m为1,2,3或4.R 7选自氢或低级烷基,及其药理学活性盐。 新化合物可用于治疗精神障碍。